Related Experiment Videos
Neuroleptic-associated hyperprolactinemia. Can it be treated with bromocriptine?
1Department of Obstetrics and Gynecology, Sinai Hospital of Baltimore, Maryland 21215.
The Journal of Reproductive Medicine
|August 1, 1992
Summary
Bromocriptine treatment helped restore menstruation in psychiatric patients with hyperprolactinemia caused by neuroleptic medications. Further research is suggested for this potential therapy.
Area of Science:
- Endocrinology
- Psychiatry
- Pharmacology
Background:
- Neuroleptic medications can cause hyperprolactinemia, leading to menstrual irregularities like amenorrhea/oligomenorrhea.
- Hyperprolactinemia is a common side effect of antipsychotic drugs, impacting reproductive health.
Purpose of the Study:
- To evaluate the efficacy of bromocriptine in treating neuroleptic-induced hyperprolactinemia and associated menstrual dysfunction.
- To assess the safety and tolerability of bromocriptine in psychiatric outpatients.
Main Methods:
- Six stable psychiatric outpatients with hyperprolactinemia and amenorrhea/oligomenorrhea were enrolled.
- Patients received daily dosages of bromocriptine ranging from 5-10 mg.
- Treatment outcomes, including hormonal levels and menstrual status, were monitored.
Main Results:
- Bromocriptine corrected hyperprolactinemia and restored menstruation in four out of six patients.
- One patient experienced worsened psychiatric symptoms, leading to bromocriptine discontinuation.
- Overall, three out of six patients achieved successful correction of menstrual irregularities.
Conclusions:
- Bromocriptine shows promise as a therapeutic option for neuroleptic-associated hyperprolactinemia and amenorrhea/galactorrhea.
- Further investigation is warranted to optimize bromocriptine use in this patient population.
- Careful monitoring for psychiatric side effects is essential during bromocriptine treatment.